Chemoembolization Endpoints: Effect on Survival Among Patients With Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chemoembolization Endpoints: Effect on Survival Among Patients With Hepatocellular Carcinoma

Published:2011-04 Issue:4 Volume:196 Page:919-928
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Jin Brian,Wang Dingxin,Lewandowski Robert J.,Riaz Ahsun,Ryu Robert K.,Sato Kent T.,Larson Andrew C.,Salem Riad,Omary Reed A.

Publisher

American Roentgen Ray Society

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference29 articles.

1. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

2. Prognostic prediction and treatment strategy in hepatocellular carcinoma

3. Treatment of hepatocellular carcinoma in patients with cirrhosis

4. Multimodality Treatment of Hepatocellular Carcinoma in a Hepatobiliary Specialty Center

5. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Locoregional interventional therapy for hepatocellular carcinoma: radiologic and clinical factors predictive of untreatable progression and time to untreatable progression;Frontiers in Pharmacology;2024-07-23

2. Embolization for Lung Tumors;Interventional Oncology;2024

3. Safety evaluation of combination treatment of drug-eluting bead transarterial chemoembolization and immune checkpoint inhibitors for hepatocellular carcinoma: An increased risk of liver abscess with treatment interval less than one month;European Journal of Radiology;2024-01

4. Multidisciplinary Taiwan consensus for the use of conventional TACE in hepatocellular carcinoma treatment;Frontiers in Oncology;2023-06-20

5. Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma;Liver Cancer;2023-05-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3